Last reviewed · How we verify
NCT06888934: LYNC
Evaluation of the Treatment of Arthritis and the Correction of Bone Alignment Default of the Toes With Lync
NA trial testing Intervention with Lync device. in Arthritis Foot in 76 participants. Currently enrolling.
1 May 2027
Quick facts
| Lead sponsor | Novastep |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 76 |
| Start date | 4 November 2024 |
| Primary completion | 1 May 2027 |
| Estimated completion | 1 May 2027 |
| Sites | 5 locations across France |
Drugs / interventions tested
- Intervention with Lync device.
Conditions studied
- Arthritis Foot — all drugs for Arthritis Foot →
- Bone Alignment Defaults — all drugs for Bone Alignment Defaults →
Sponsor
Novastep
Who can join
18 and older, any sex, with Arthritis Foot or Bone Alignment Defaults. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The "LYNC" clinical investigation aims to confirm the clinical benefits, performance and safety of the Lync® device when implanted in the toes for the treatment of arthritis and correction of bone misalignments. The main objective of the study is to confirm the clinical benefits of the Lync® device for the treatment of arthritis and the correction of bone alignment default, by evaluating the restoration of the functional capacities of the forefoot at 3 -4 months post-operative follow-up with AOFAS-LMIS score.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06888934
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Novastep trials
Trials by the same sponsor.
- NCT05361317 — Correction of Hallux Valgus with the Nexis® PECA Bunion Implantable Osteosynthesis Medical Device · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06888934 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Novastep
- Last refreshed: 21 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06888934.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing